Objectives: Follow-up of the clinical evolution and response to treatment of a 27-year-old patient with Hodgkin’s Lymphoma- histological subtype mixed cellularity- chemorefractory.

Material and method: Retrospective study in which was analysed the response of a refractory patient to different lines of chemotherapy.

Outcomes: The results showed the evolution of the patient’s disease with an initial complete response, with a relapse 18 months after the first line of chemotherapy, refractory to multiple subsequent treatments, but with a favorable response to the new type of treatment.

Conclusions: Diagnosis and evaluation of treatment response in one patient with Hodgkin’s Lymphoma refractory to multiple chemotherapy lines, with good evolution after FEAM-ASCT.

TBA